Jarvis Martin J, Fidler Jennifer, Mindell Jennifer, Feyerabend Colin, West Robert
Health Behaviour Research Centre, and Department of Epidemiology and Public Health, University College London, London, UK.
Addiction. 2008 Sep;103(9):1553-61. doi: 10.1111/j.1360-0443.2008.02297.x.
To reassess saliva cotinine cut-points to discriminate smoking status. Cotinine cut-points that are in use were derived from relatively small samples of smokers and non-smokers 20 or more years ago. It is possible that optimal cut-points may have changed as prevalence and exposure to passive smoking have declined.
Cross-sectional survey of the general population, with assessment of self-reported smoking and saliva cotinine.
A total of 58 791 respondents aged 4 years and older in the Health Survey for England for the years 1996-2004 who provided valid saliva cotinine specimens.
Saliva cotinine concentrations, demographic variables, self-reported smoking, presence or absence of smoking in the home, a composite index of social disadvantage derived from occupation, housing tenure and access to a car.
A cut-point of 12 ng/ml performed best overall, with specificity of 96.9% and sensitivity of 96.7% in discriminating confirmed cigarette smokers from never regular smokers. This cut-point also identified correctly 95.8% of children aged 8-15 years smoking six or more cigarettes a week. There was evidence of substantial misreport in claimed ex-smokers, especially adolescents (specificity 72.3%) and young adults aged 16-24 years (77.5%). Optimal cut-points varied by presence (18 ng/ml) or absence (5 ng/ml) of smoking in the home, and there was a gradient from 8 ng/ml to 18 ng/ml with increasing social disadvantage.
The extent of non-smokers' exposure to other people's tobacco smoke is the principal factor driving optimal cotinine cut-points. A cut-point of 12 ng/ml can be recommended for general use across the whole age range, although different cut-points may be appropriate for population subgroups and in societies with differing levels of exposure to secondhand smoke.
重新评估唾液可替宁切点以鉴别吸烟状态。目前使用的可替宁切点源自20多年前规模相对较小的吸烟者和非吸烟者样本。随着吸烟率及被动吸烟暴露率的下降,最佳切点可能已经发生变化。
对普通人群进行横断面调查,评估自我报告的吸烟情况和唾液可替宁水平。
1996 - 2004年英格兰健康调查中4岁及以上的58791名受访者,他们提供了有效的唾液可替宁样本。
唾液可替宁浓度、人口统计学变量、自我报告的吸烟情况、家中是否有人吸烟、根据职业、住房 tenure 和是否有车得出的社会劣势综合指数。
总体而言,12 ng/ml的切点表现最佳,在鉴别确诊吸烟者与从不经常吸烟者时,特异性为96.9%,敏感性为96.7%。该切点还能正确识别95.8%每周吸烟6支或更多的8 - 15岁儿童。有证据表明,自称已戒烟者存在大量误报情况,尤其是青少年(特异性72.3%)和16 - 24岁的年轻人(77.5%)。最佳切点因家中是否有人吸烟(有则为18 ng/ml,无则为5 ng/ml)而异,且随着社会劣势程度增加,切点从8 ng/ml到18 ng/ml呈梯度变化。
非吸烟者接触他人烟草烟雾的程度是驱动最佳可替宁切点的主要因素。尽管不同切点可能适用于不同人群亚组以及二手烟暴露水平不同的社会,但可推荐12 ng/ml的切点在全年龄范围内普遍使用。